دورية أكاديمية

Assessment of inter-operator variability in peripheral monocyte subset gating strategy using flow cytometry in patients with suspected acute stroke.

التفاصيل البيبلوغرافية
العنوان: Assessment of inter-operator variability in peripheral monocyte subset gating strategy using flow cytometry in patients with suspected acute stroke.
المؤلفون: Heng E; INSERM, Innovative Therapies in Haemostasis, Université Paris Cité, Paris, France.; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France., Neuwirth M; INSERM, Innovative Therapies in Haemostasis, Université Paris Cité, Paris, France.; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France., Mas F; R&D Hematology and Hemostasis department, Biocytex, Marseille, France., Contant G; Recherche prospective, Diagnostica Stago, Gennevilliers, France., Mazighi M; Unité Neuro-vasculaire, Hôpital Lariboisière, APHP.Nord, Paris, France., Feriel J; Développement clinique, Diagnostica Stago, Asnières-sur-Seine, France., Montpellier B; R&D Hematology and Hemostasis department, Biocytex, Marseille, France., Brumpt C; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France., Jourdi G; INSERM, Innovative Therapies in Haemostasis, Université Paris Cité, Paris, France.; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France., Curis E; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France.; UR 7537 BioSTM (Biostatistics), Faculté de Pharmacie de Paris, Université Paris Cité, Paris, France., Siguret V; INSERM, Innovative Therapies in Haemostasis, Université Paris Cité, Paris, France.; Service d'Hématologie Biologique, Hôpital Lariboisière, APHP.Nord, Paris, France.
المصدر: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2024 Mar; Vol. 105 (3), pp. 171-180. Date of Electronic Publication: 2023 Nov 28.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235694 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4930 (Electronic) Linking ISSN: 15524922 NLM ISO Abbreviation: Cytometry A Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hoboken, N.J. : Wiley-Liss, c2002-
مواضيع طبية MeSH: Monocytes*/metabolism , HLA-DR Antigens*, Humans ; Flow Cytometry ; Biomarkers/metabolism
مستخلص: Background: Innovative tools to reliably identify patients with acute stroke are needed. Peripheral monocyte subsets, that is, classical-Mon1, intermediate-Mon2, and non-classical-Mon3, with their activation marker expression analyzed using flow-cytometry (FCM) could be interesting cell biomarker candidates.
Aim: To assess the inter-operator variability in a new peripheral monocyte subset gating strategy using FCM in patients with suspected acute stroke.
Methods: In BOOST-study ("Biomarkers-algOrithm-for-strOke-diagnoSis-and Treatment-resistance-prediction," NCT04726839), patients ≥18 years with symptoms suggesting acute stroke within the last 24 h were included. Blood was collected upon admission to emergency unit. FCM analysis was performed using the FACS-CANTO-II® flow-cytometer and Flow-Jo™-software. Analyzed markers were CD45/CD91/CD14/CD16 (monocyte backbone) and CD62L/CD11b/HLA-DR/CD86/CCR2/ICAM-1/CX3CR1/TF (activation markers). Inter-operator agreement (starting from raw-data files) was quantified by the measure distribution and, for each patient, the coefficient of variation (CV).
Results: Three operators analyzed 20 patient blood samples. Median inter-operator CVs were below the pre-specified tolerance limits (10% [for Mon1 counts], 20% [Mon2, Mon3 counts], 15% [activation marker median-fluorescence-intensities]). We observed a slight, but systematic, inter-operator effect. Overall, absolute inter-operator differences in fractions of monocyte subsets were <0.03.
Conclusion: Our gating strategy allowed monocyte subset gating with an acceptable inter-operator variability. Although low, the inter-operator effect should be considered in monocyte data analysis of BOOST-patients.
(© 2023 The Authors. Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.)
References: Kaito M, Araya S, Gondo Y, Fujita M, Minato N, Nakanishi M, et al. Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients. PLoS One. 2013;8(8):e69409.
Zawada AM, Fell LH, Untersteller K, Seiler S, Rogacev KS, Fliser D, et al. Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe study. Cytometry A. 2015;87:750-758.
ElAli A, Jean LBN. The role of monocytes in ischemic stroke pathobiology: new avenues to explore. Front Aging Neurosci. 2016;8:29.
Tahir S, Steffens S. Nonclassical monocytes in cardiovascular physiology and disease. Am J Physiol Cell Physiol. 2021;320:C761-C770.
Ptaszyńska-Kopczyńska K, Eljaszewicz A, Marcinkiewicz-Siemion M, Sawicka-Śmiarowska E, Tarasiuk E, Lisowska A, et al. Monocyte subsets in patients with chronic heart failure treated with cardiac resynchronization therapy. Cell. 2021;10:3482.
Boidin M, Lip GYH, Shantsila A, Thijssen D, Shantsila E. Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI. Sci Rep. 2023;13:48.
Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74-e80.
Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118:e16-e31.
Hudig D, Hunter KW, Diamond WJ, Redelman D, Properties of Human Blood Monocytes. I. CD91 expression and log orthogonal light scatter provide a robust method to identify monocytes that is more accurate than CD14 expression. Cytometry B Clin Cytom. 2014;86B:111-120.
Hudig D, Hunter KW, Diamond WJ, Redelman D. Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals. Cytometry B Clin Cytom. 2014;86B:121-134.
Thomas GD, Hamers AAJ, Nakao C, Marcovecchio P, Taylor AM, McSkimming C, et al. Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry. Arterioscler Thromb Vasc Biol. 2017;37:1548-1558.
Williams H, Mack C, Baraz R, Marimuthu R, Naralashetty S, Li S, et al. Monocyte differentiation and heterogeneity: inter-subset and interindividual differences. Int J Mol Sci. 2023;24:8757.
Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, et al. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) working groups “Atherosclerosis & Vascular Biology” and “thrombosis”. Thromb Haemost. 2016;116:626-637.
Clinical and laboratory standards institute (CLSI). Validation of assays performed by flow cytometry. CLSI guideline H62. 1st ed. CLSI, USA; 2021.
Bates D, Maechler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1-48.
Tarfi S, Harrivel V, Dumezy F, Guy J, Roussel M, Mimoun A, et al. Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis. Blood. Cancer J. 2018;8:114.
Zhuang J, Han Y, Xu D, Zhu G, Singh S, Chen L, et al. Comparison of circulating dendritic cell and monocyte subsets at different stages of atherosclerosis: insights from optical coherence tomography. BMC Cardiovasc Disord. 2017;17:270.
معلومات مُعتمدة: ANR-18-RHUS-0001 Agence Nationale de la Recherche; Biocytex
فهرسة مساهمة: Keywords: activation markers; flow cytometry; inter-operator variability; monocyte; stroke
المشرفين على المادة: 0 (HLA-DR Antigens)
0 (Biomarkers)
تواريخ الأحداث: Date Created: 20231116 Date Completed: 20240315 Latest Revision: 20240408
رمز التحديث: 20240408
DOI: 10.1002/cyto.a.24810
PMID: 37971361
قاعدة البيانات: MEDLINE
الوصف
تدمد:1552-4930
DOI:10.1002/cyto.a.24810